Other
Psilocybin-Assisted Psychotherapy
0
Pipeline Programs↗
7
Active Trials↗
1
Companies Involved↗
Psilocybin-Assisted Psychotherapy is an early-stage landscape with 0 programs across 1 company. The most active players are Clairvoyant Therapeutics.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
9
clinical trials
Recruiting5 · 56%
Not yet recruiting2 · 22%
Unknown status2 · 22%
Clinical Trials
Trial Activity
9 trials
Safety and Efficacy of Psilocybin-assisted Psychotherapy for Demoralization Syndrome in Patients Diagnosed With Advanced Stage Cancer
Recruiting·—·Phase 1·NCT06818994·15 enrolled
Understanding Music and Mindfulness Preferences in Psilocybin-Assisted Psychotherapy
Not yet recruiting·—·Phase 2·NCT07373535·16 enrolled
Psilocybin-Assisted Psychotherapy for the Treatment of Severe Alcohol Use Disorder
Not yet recruiting·—·Phase 2·NCT07296094·36 enrolled
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)